172 related articles for article (PubMed ID: 12790794)
1. Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.
Hamelers IH; Steenbergh PH
Endocr Relat Cancer; 2003 Jun; 10(2):331-45. PubMed ID: 12790794
[TBL] [Abstract][Full Text] [Related]
2. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
4. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factors and breast cancer.
Lee AV; Yee D
Biomed Pharmacother; 1995; 49(9):415-21. PubMed ID: 8746077
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol.
Daws MR; Westley BR; May FE
Endocrinology; 1996 Apr; 137(4):1177-86. PubMed ID: 8625887
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
8. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
[TBL] [Abstract][Full Text] [Related]
9. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
Lee AV; Weng CN; Jackson JG; Yee D
J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
11. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
[TBL] [Abstract][Full Text] [Related]
12. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
[TBL] [Abstract][Full Text] [Related]
13. Role of insulin-like growth factor binding protein-3 in breast cancer cell growth.
Schedlich LJ; Graham LD
Microsc Res Tech; 2002 Oct; 59(1):12-22. PubMed ID: 12242693
[TBL] [Abstract][Full Text] [Related]
14. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
[TBL] [Abstract][Full Text] [Related]
15. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells.
Chen WF; Wong MS
J Clin Endocrinol Metab; 2004 May; 89(5):2351-9. PubMed ID: 15126563
[TBL] [Abstract][Full Text] [Related]
16. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.
van der Burg B; Isbrücker L; van Selm-Miltenburg AJ; de Laat SW; van Zoelen EJ
Cancer Res; 1990 Dec; 50(24):7770-4. PubMed ID: 2174732
[TBL] [Abstract][Full Text] [Related]
17. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
[TBL] [Abstract][Full Text] [Related]
18. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.
Martin JL; Coverley JA; Pattison ST; Baxter RC
Endocrinology; 1995 Mar; 136(3):1219-26. PubMed ID: 7532580
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.
Surmacz E; Burgaud JL
Clin Cancer Res; 1995 Nov; 1(11):1429-36. PubMed ID: 9815941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
